References

Effects of insulin resistance on endothelial progenitor cells and vascular repair

10.1042/cs20080263 · 2009 · External reference

Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia

10.1161/01.cir.0000046450.89986.50 · 2003 · External reference

Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors

10.1016/s1050-1738(01)00128-1 · 2001 · External reference

Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial

10.1002/stem.207 · 2009 · External reference

Endothelial progenitor cells and cardiovascular cell-based therapies

10.1080/14653240802714827 · 2009 · External reference

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

10.1056/nejmoa022287 · 2003 · External reference

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

10.1161/hh1301.093953 · 2001 · External reference

Circulating progenitor cells are reduced in patients with severe lung disease

10.1634/stemcells.2005-0440 · 2006 · External reference

Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis

10.1161/01.cir.0000081703.34526.5d · 2003 · External reference

Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes

10.2337/diabetes.53.1.195 · 2004 · External reference

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

10.1161/01.cir.0000039526.42991.93 · 2002 · External reference

Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors

10.1111/j.1523-1755.2005.00261.x · 2005 · External reference

Impaired function of circulating CD34(+) CD45(−) cells in patients with proliferative diabetic retinopathy

10.1016/j.exer.2010.05.012 · 2010 · External reference

Vascular endothelial growth factor (VEGF) and its receptors

10.1096/fasebj.13.1.9 · 1999 · External reference

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

10.1161/01.res.85.3.221 · 1999 · External reference

Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration

10.1161/hc0602.103673 · 2002 · External reference

Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis

10.1172/jci24726 · 2005 · External reference

Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy

10.2337/diabetes.54.6.1823 · 2005 · External reference

Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers

10.1161/01.atv.0000135655.52088.c5 · 2004 · External reference

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

10.1016/s0140-6736(02)09670-8 · 2002 · External reference

Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia

10.1253/circj.71.196 · 2007 · External reference

Circulating endothelial progenitor cells and cardiovascular outcomes

10.1056/nejmoa043814 · 2005 · External reference

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

10.1161/01.cir.0000124476.32871.e3 · 2004 · External reference

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

10.1038/nm1095-1024 · 1995 · External reference

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

10.1074/jbc.273.46.30336 · 1998 · External reference

Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance

10.2337/diabetes.55.03.06.db05-0771 · 2006 · External reference

p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway

10.1074/jbc.m405777200 · 2004 · External reference

Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice

10.2337/db09-0136 · 2009 · External reference

Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI

10.1038/ncpcardio0430 · 2006 · External reference

Effects of diabetes mellitus on VEGF-induced proliferation response in bone marrow derived endothelial progenitor cells

10.1111/j.1540-8191.2010.01086.x · 2010 · External reference